Keros Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Keros Therapeutics, Inc. (KROS) reported Basic Shares Outstanding (Weighted Average) of 19.80 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 19.80M shares, a 51.25% decline year-over-year.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 19.63M shares, a 51.60% decline year-over-year.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 27.09M shares, a 32.88% decline year-over-year.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 40.62M shares, a 8.07% increase year-over-year.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 37.22M shares, a 0.58% decline from fiscal 2024.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 37.44M shares, a 27.14% increase from fiscal 2023.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 29.45M shares, a 16.66% increase from fiscal 2022.
- Keros Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 25.24M shares, a 8.17% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 19.80M shares 10-Q · filed 2026-08-03 | 19.72M shares 10-Q · filed 2026-08-03 | 22.17M shares derived: average of 3 quarters · filed 2026-08-03 | 26.79M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 19.63M shares 10-Q · filed 2026-05-14 | 23.36M shares derived: average of 2 quarters · filed 2026-05-14 | 29.11M shares derived: average of 3 quarters · filed 2026-05-14 | 31.99M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 27.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 33.86M shares derived: average of 2 quarters · filed 2026-03-04 | 36.11M shares derived: average of 3 quarters · filed 2026-08-03 | 37.22M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 40.62M shares 10-Q · filed 2025-11-05 | 40.62M shares derived: average of 2 quarters · filed 2026-08-03 | 40.60M shares 10-Q · filed 2025-11-05 | 40.54M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 40.61M shares 10-Q · filed 2026-08-03 | 40.59M shares 10-Q · filed 2026-08-03 | 40.51M shares derived: average of 3 quarters · filed 2026-08-03 | 39.78M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 40.56M shares 10-Q · filed 2026-05-14 | 40.46M shares derived: average of 2 quarters · filed 2026-05-14 | 39.50M shares derived: average of 3 quarters · filed 2026-05-14 | 38.65M shares derived: average of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 40.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 38.97M shares derived: average of 2 quarters · filed 2026-03-04 | 38.02M shares derived: average of 3 quarters · filed 2026-03-04 | 37.44M shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 37.59M shares 10-Q · filed 2025-11-05 | 36.85M shares derived: average of 2 quarters · filed 2025-11-05 | 36.46M shares 10-Q · filed 2025-11-05 | 34.88M shares derived: average of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | 36.10M shares 10-Q · filed 2025-08-06 | 35.89M shares 10-Q · filed 2025-08-06 | 33.97M shares derived: average of 3 quarters · filed 2025-08-06 | 32.90M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 35.69M shares 10-Q · filed 2025-05-06 | 32.91M shares derived: average of 2 quarters · filed 2025-05-06 | 31.83M shares derived: average of 3 quarters · filed 2025-05-06 | 31.27M shares derived: average of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | 30.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 29.90M shares derived: average of 2 quarters · filed 2025-02-26 | 29.80M shares derived: average of 3 quarters · filed 2025-02-26 | 29.45M shares 10-K · filed 2025-02-26 |
| 2023-09-30 | 29.67M shares 10-Q · filed 2024-11-06 | 29.64M shares derived: average of 2 quarters · filed 2024-11-06 | 29.22M shares 10-Q · filed 2024-11-06 | 28.75M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 29.60M shares 10-Q · filed 2024-08-07 | 28.99M shares 10-Q · filed 2024-08-07 | 28.44M shares derived: average of 3 quarters · filed 2025-02-26 | 27.72M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 28.37M shares 10-Q · filed 2024-05-08 | 27.86M shares derived: average of 2 quarters · filed 2025-02-26 | 27.09M shares derived: average of 3 quarters · filed 2025-02-26 | 26.33M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 27.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 26.45M shares derived: average of 2 quarters · filed 2025-02-26 | 25.65M shares derived: average of 3 quarters · filed 2025-02-26 | 25.24M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 25.55M shares 10-Q · filed 2023-11-06 | 24.80M shares derived: average of 2 quarters · filed 2023-11-06 | 24.54M shares 10-Q · filed 2023-11-06 | 24.26M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 24.05M shares 10-Q · filed 2023-08-07 | 24.02M shares 10-Q · filed 2023-08-07 | 23.83M shares derived: average of 3 quarters · filed 2024-02-28 | 23.71M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 23.99M shares 10-Q · filed 2023-05-04 | 23.72M shares derived: average of 2 quarters · filed 2024-02-28 | 23.60M shares derived: average of 3 quarters · filed 2024-02-28 | 23.52M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 23.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 23.40M shares derived: average of 2 quarters · filed 2024-02-28 | 23.37M shares derived: average of 3 quarters · filed 2024-02-28 | 23.33M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 23.36M shares 10-Q · filed 2022-11-03 | 23.33M shares derived: average of 2 quarters · filed 2022-11-03 | 23.30M shares 10-Q · filed 2022-11-03 | 22.89M shares derived: average of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | 23.31M shares 10-Q · filed 2022-08-04 | 23.27M shares 10-Q · filed 2022-08-04 | 22.73M shares derived: average of 3 quarters · filed 2022-08-04 | 22.09M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 23.23M shares 10-Q · filed 2022-05-05 | 22.45M shares derived: average of 2 quarters · filed 2022-05-05 | 21.69M shares derived: average of 3 quarters · filed 2022-05-05 | 20.67M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 21.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 20.92M shares derived: average of 2 quarters · filed 2022-03-09 | 19.82M shares derived: average of 3 quarters · filed 2022-03-09 | 15.51M shares 10-K · filed 2022-03-09 |
| 2020-09-30 | 20.18M shares 10-Q · filed 2021-11-04 | 18.90M shares derived: average of 2 quarters · filed 2021-11-04 | 13.45M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 17.62M shares 10-Q · filed 2021-08-05 | 10.05M shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |